{
    "pmcid": "11036486",
    "summary": "The paper \"Combining Rosetta Sequence Design with Protein Language Model Predictions Using Evolutionary Scale Modeling (ESM) as Restraint\" explores the integration of machine learning-based protein language models (PLMs) with traditional structure-based protein design methods, specifically using the Rosetta software suite. The focus is on improving the design of protein sequences, including potential SARS-CoV-2 nanobody binders, by leveraging evolutionary information encoded in PLMs to guide Rosetta's design protocols.\n\n### Key Insights on Rosetta in Designing SARS-CoV-2 Nanobody Binders:\n\n1. **Rosetta's Role in Protein Design**:\n   - Rosetta is a well-established tool for computational protein design, primarily using biophysical principles to create stable and functional proteins. It has been instrumental in designing novel enzymes, antibodies, and de novo proteins.\n   - The software suite includes protocols like FixBB and LayerDesign, which are used to design protein sequences by optimizing the energy function based on structural constraints.\n\n2. **Challenges with Rosetta-Designed Sequences**:\n   - The study found that sequences designed by Rosetta often scored worse in terms of PLM metrics compared to their native counterparts. This indicates a gap between Rosetta's structural optimization and the evolutionary plausibility of the sequences.\n   - Rosetta's designs showed biases, particularly in surface amino acid composition, where aliphatic residues were often placed in positions where PLMs predicted polar charged residues to be more likely.\n\n3. **Integration with Protein Language Models**:\n   - The paper introduces a novel approach by integrating PLM predictions, specifically from the Evolutionary Scale Modeling (ESM) model, into Rosetta's design process.\n   - By incorporating a PLM-derived position-specific probability matrix (PSPM) into the Rosetta energy function, the design process is restrained to favor sequences that are more evolutionarily plausible.\n\n4. **Improvement in Sequence Design**:\n   - The integration of PLM predictions led to sequences with better PLM scores, indicating a closer alignment with natural evolutionary patterns, while maintaining similar thermodynamic stability as assessed by Rosetta.\n   - This approach resulted in sequences that are more likely to be stable and functional, potentially improving the design of nanobody binders against targets like the SARS-CoV-2 spike protein.\n\n5. **Implications for Nanobody Design**:\n   - For designing SARS-CoV-2 nanobody binders, the combination of PLM predictions with Rosetta can help identify sequences that not only fit the structural requirements but also have a higher likelihood of being functional and stable in a biological context.\n   - This method can enhance the virtual screening process by narrowing down the sequence space to those with higher evolutionary fitness, potentially leading to more effective nanobody candidates.\n\n6. **Validation and Future Directions**:\n   - The study validated the designed sequences using independent methods like ProteinMPNN and OmegaFold, showing that the PLM-restrained designs performed well in terms of predicted structure and stability.\n   - Future work could involve experimental validation of these designs, particularly for SARS-CoV-2 nanobody binders, to confirm their efficacy and stability in real-world applications.\n\nIn summary, the paper demonstrates that integrating PLM predictions with Rosetta's design protocols can significantly enhance the evolutionary plausibility of designed protein sequences, which is crucial for applications like designing effective SARS-CoV-2 nanobody binders. This approach represents a promising direction for combining machine learning with traditional computational biology tools to advance protein engineering.",
    "title": "Combining Rosetta Sequence Design with Protein Language Model Predictions Using Evolutionary Scale Modeling (ESM) as Restraint"
}